Propria was founded in 2018 with the goal of making engineered heart tissue (EHT) more powerful and accessible to scientists. Propria's approach is based on technology licensed from the laboratory of co-founder Dr. Stuart Campbell, Associate Professor of Biomedical Engineering at Yale University. 

 

With colleagues at Yale, Dr. Campbell developed a new method of generating exceptionally thin and functionally mature cardiac tissue constructs ideal for biomechanical study. Propria engineers have refined this technique into a system that can be broadly adopted by laboratories that work with iPSC-derived cardiomyocytes.